Showing results (191-200 of 426) with videos related to

Sort By:
Pageof 43
Leukemia Research|February 2, 2006
Genomic imbalances and patterns of karyotypic variability in mantle-cell lymphoma cell linesJordi Camps, Itziar Salaverria, Maria J Garcia, et al.
British Journal of Cancer|March 9, 2016
MYC functions are specific in biological subtypes of breast cancer and confers resistance to endocrine therapy in luminal tumoursAndrew R Green, Mohammed A Aleskandarany, Devika Agarwal, et al.
Oncotarget|September 17, 2017
Data-driven analysis of immune infiltrate in a large cohort of breast cancer and its association with disease progression, ER activity, and genomic complexityRuth Dannenfelser, Marianne Nome, Andliena Tahiri, et al.
Nucleic Acids Research|August 24, 2018
SOX4 can redirect TGF-β-mediated SMAD3-transcriptional output in a context-dependent manner to promote tumorigenesisStephin J Vervoort, Ana Rita Lourenço, Ana Tufegdzic Vidakovic, et al.
Cell Systems|May 1, 2021
Deciphering the signaling network of breast cancer improves drug sensitivity predictionMarco Tognetti, Attila Gabor, Mi Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 8, 2014
TP53 mutation spectrum in breast cancer is subtype specific and has distinct prognostic relevanceLaxmi Silwal-Pandit, Hans Kristian Moen Vollan, Suet-Feung Chin, et al.
Nature Genetics|August 5, 2020
Landscape of G-quadruplex DNA structural regions in breast cancerRobert Hänsel-Hertsch, Angela Simeone, Abigail Shea, et al.
Molecular Cancer Research : MCR|October 30, 2014
Lymphocyte Invasion in IC10/Basal-Like Breast Tumors Is Associated with Wild-Type TP53David Quigley, Laxmi Silwal-Pandit, Ruth Dannenfelser, et al.
BMC Medicine|December 31, 2015
A nested cohort study of 6,248 early breast cancer patients treated in neoadjuvant and adjuvant chemotherapy trials investigating the prognostic value of chemotherapy-related toxicitiesJean E Abraham, Louise Hiller, Leila Dorling, et al.
International Journal of Cancer|March 14, 2013
Prognosis of early breast cancer by immunohistochemistry defined intrinsic sub-types in patients treated with adjuvant chemotherapy in the NEAT/BR9601 trialAlaa M Ali, Elena Provenzano, John M S Bartlett, et al.
Pageof 43